Dr. David Christopher Mancini, MD

Dr. Mancini practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Mancini's NPI, 1699122358, was assigned on May 23, 2016. Dr. Mancini graduated from St. George's University School of Medicine in 2016. Dr. Mancini's Maryland license number on file is D0091341.

Dr. Mancini's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Mancini's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Mancini is also affiliated with University of Maryland Medical Center Midtown Campus. The medical group on file is University of Maryland Psychiatry Associates, P.A.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mancini practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Mancini's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Mancini is board certified in forensic psychiatry by the American Board of Psychiatry and Neurology. Dr. Mancini has a license on file in Maryland.

Dmand AI lists anxiety among the conditions Dr. Mancini treats.

CMS data shows 51 Medicare services from Dr. Mancini across 1 procedure code in 2024, for 63 Medicare patients. Medicare paid $3,265 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 63 Medicare patients who saw Dr. Mancini in 2024. The largest group is under 65, with 28 patients. 75% of them have high blood pressure, and 75% have mood disorders. 63% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mancini's median patient age at 46, with 53% women.

In 2024, Dr. Mancini wrote 31 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $87 in total drug cost. In 2022, CMS named 24 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mancini for performance year 2024, reported as part of a group. Dr. Mancini accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Mancini in 2023. Dr. Mancini's most frequent co-authors are Argyro Athanasiadi, MD, MS, Nithya Cherukuru, MD and David Brian Glovinsky, MD.

Dr. Mancini graduated from St. George's University School of Medicine in 2016.

Dr. Mancini is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CareFirst BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.